Abstract
Mutagenicity, expressed as the number of his + revenants per μmole of test compound per hour of exposure, was estimated in two strains of S. typhimurium in the presence of a postmitochondrial mouse-liver supernatant, following exposure to vapours of one of a series of halo-olefins. Their activity was in the following descending order: 3,4-dichlorobutene-1 > 1-chlorobutadiene (technical grade) > 2-chlorobutadiene > vinyl bromide > vinylidene chloride > vinyl chloride; marginal mutagenicity was detected in the presence of 1,1,2-trichloroethylene and 1,1-difluoroethylene, and none with tetrachloroethylene and vinyl acetate. Liver fractions from humans converted vinyl chloride, vinyl bromide, vinylidene chloride and 2-chlorobutadiene into mutagens. In the plate incorporation assay, 1,4-dichlorobutene-2 was mutagenic per se, and addition of microsomal fractions from human or mouse liver enhanced the mutagenicity; a synthetic putative metabolite, 1,4-dichloro-2,3-epoxybutane was less mutagenic than the parent olefin in strain TA100. Treatment of rats with phenobarbital or 3-methylcholanthrene caused an up to 2-fold increase in the liver microsome-mediated mutagenicities of vinyl chloride and vinylidene chloride in S. typhimurium TA1530; while treatment with pregnenolone-16α-carbonitrile, aminoacetonitrile or disulfiram decreased the mutagenic effects. Vinyl chloride, and probably vinyl bromide, were shown to be epoxidized by mouse-liver microsomes; volatile alkylating metabolites were trapped by reaction with excess 4-(4-nitrobenzyl)pyridine and analysed spectrally. 2-Chlorobutadiene also yielded an alkylating intermediate, but 1,1-difluoroethylene, 1,1-dichloroethyleneand 1,1,2-trichloroethylene did not. 2-Chloro- and 1-chlorobutadiene, 3,4-dichlorobutene-1, 1,4-dichlorobutene-2 and its 2,3-epoxy derivative showed alkylating activity with 4-(4-nitrobenzyl)pyridine, which was not related quantitatively to mutagenic activity in S. typhimurium TA100 in the absence of a metabolic activation system. These data support the hypothesis that an oxidation of the double bond in certain halo-olefins, which is dependent on microsomal mono-oxygenases is a common pathway in the formation of biologically reactive intermediates. The relevance of the metabolites formed during such oxidative processes to the mutagenic, toxic and carcinogenic activities in vivo of some of the parent compounds is discussed.
Zusammenfassung
Die mutagene Wirkung einer Reihe halogenierter Kohlenwasserstoffe wurde in Gegenwart einer postmitochondrialen Mäuseleberfraktion in zwei Stämmen von S. typhimurium gemessen. Wenn die Bakterien den gasförmigen Testsubstanzen ausgesetzt wurden, war die Mutagenität in folgender Reihenfolge: 3,4-Dichlorbuten-1 > 1-Chlorbutadien (technischer Reinheitsgrad) > 2-Chlorbutadien > Vinylbromid > Vinylidenchlorid > Vinylchlorid. 1,1,2-Trichloräthylen und 1,1-Difluoräthylen zeigten schwachen, Tetrachloräthylen und Vinylacetat keinen mutagenen Effekt. Gewebefraktionen von Menschenleber konnten Vinylchlorid, Vinylbromid, Vinylidenchlorid und 2-Chlorbutadien in mutagene Metabolite überführen. Im konventionellen Plattentest zeigte 1,4-Dichlorbuten-1 eine direkte mutagene Wirkung, die durch Zusatz von mikrosomalen Leberfraktionen von Menschen oder von der Maus erhöht wurde. Der vermutete reaktive Metabolit 1,4-Dichlor-2,3-Epoxybutan wurde synthetisiert, erwies sich aber im Stamm TA100 als ein schwächeres Mutagen als die Muttersubstanz. Die Vorbehandlung von Ratten mit Phenobarbital oder 3-Methylcholanthren verdoppelte die mikrosomenabhängige Mutagenität von Vinylchlorid und Vinylidenchlorid in S. typhimurium TA1530, Pregnenolon-16α-Carbonitril, Aminoacetonitril oder Disulfiram dagegen verminderten die mutagene Wirkung. Eine Epoxidierung von Vinylchlorid und wahrscheinlich Vinylbromid durch Mäuselebermikrosomen wurde durch die Bildung und Abfangen von flüchtigen, alkylierenden Metaboliten mit 4-(4-Nitrobenzyl)pyridin sowie spektralen Untersuchungen nachgewiesen; 2-Chlorbutadien bildete ebenfalls eine alkylierende Zwischenstufe, die in ähnlichen Experimenten mit 1,1-Difluoräthylen, 1,1-Dichloräthylen und 1,1,2-Trichloräthylen nicht nachgewiesen werden konnte. 2-Chlor- und 1-Chlorbutadien, 3,4-Dichlorbuten-1,1,4-Dichlorbuten-2 und sein 2,3-Epoxid zeigten alkylierende Wirkung in Gegenwart von 4-(4-Nitrobenzyl)pyridin, die sich quantitativ nicht mit der mutagenen Aktivität in S. typhimurium TA100 in Abwesenheit metabolischer Aktivierung korrelieren ließ. Die Ergebnisse zeigen einen gemeinsamen Bildungsweg in halogenierten Olefinen auf, der über eine mikrosomale Oxidation der Doppelbindung zu biologisch reaktiven Zwischenstufen führt. Die Bedeutung derartig gebildeter Metabolite für die mutagene, toxische und karzinogene Wirkung der Muttersubstanzen in vivo wird zusammenfassend erörtert.
Similar content being viewed by others
Abbreviations
- VC:
-
Vinyl chloride
- VDC:
-
Vinylidene chloride
- CBD:
-
2-Chloro-1,3-butadiene
- PB:
-
Phenobarbital
- S-9:
-
9000 × g tissue supernatant
- NBP:
-
4-(4-Nitrobenzyl)pyridine
- G 6-P:
-
Glucose 6-phosphate
- NADP+ :
-
Nicotinamide adenine dinucleotide phosphate
References
Ames, B. N., McCann, J., Yamasaki, E.: Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31, 347–364 (1975)
Andersen, M. E., Jones, R. A., Jenkins, L. L.: Enhancement of 1,1-dichloroethylene toxicity by pretreatment of fasted male rats with 2,3-epoxypropan-1-ol. Drug Chem. Toxicol. 1, 63–74 (1977–1978)
Barbin, A., Brésil, H., Croisy, A., Jacquignon, P., Malaveille, C., Montesano, R., Bartsch, H.: Liver microsome-mediated formation of alkylating agents from vinyl bromide and vinyl chloride. Biochem. Biophys. Res. Commun. 67, 596–603 (1975)
Barbin, A., Planche, G., Croisy, A., Malaveille, C., Bartsch, H.: Detection of electrophilic metabolites of halogenated olefins with 4-(4-nitrobenzyl)pyridine (NBP) or with Salmonella typhimurium. In: Second International Conference on Environmental Mutagens, Abstract, p. 59. Edinburgh, 1977
Bartsch, H., Loprieno, N.: Vinyl chloride (VCM): An example for evaluating adverse biological effects in short-term tests. In: Proc. of the 6th EEMS-meeting, Gernrode, GDR, pp. 161–165. Berlin: Akademie-Verlag 1977
Bartsch, H., Montesano, R.: Mutagenic and carcinogenic effects of vinyl chloride. Mutat. Res. 32, 93–114 (1975)
Bartsch, H., Malaveille, C., Montesano, R.: Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains. Int. J. Cancer 15, 429–437 (1975a)
Bartsch, H., Malaveille, C., Montesano, R., Tomatis, L.: Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium. Nature 255, 641–643 (1975b)
Bartsch, H., Malaveille, C., Barbin, A., Planche, G., Montesano, R.: Alkylating and mutagenic metabolites of halogenated olefins produced by human and animal tissues. Proc. Amer. Ass. Cancer Res. 17, 17 (1976a)
Bartsch, H., Malaveille, C., Barbin, A., Brésil, H., Tomatis, L., Montesano, R.: Mutagenicity and metabolism of vinyl chloride and related compounds. Environ. Health Perspect. 17, 193–198 (1976b)
Bolanowska, W., Golacka, J.: Inhalation and excretion of tetrachloroethylene in men in experimental conditions. Med. Pracy 23, 109–119 (1972)
Bolt, H. M.: Metabolic activation of halogenated ethylenes. In: Primary liver tumors. Remmer, Bolt, Bannasch and Popper (eds.), pp. 285–294. Lancaster UK: MTP Press 1978
Bolt, H. M., Kappus, H., Buchter, A., Bolt, W.: Disposition of 1,2-14C-vinyl chloride in the rat. Arch. Toxicol. (Berl.) 35, 153–162 (1976)
Bonse, G., Urban, T., Reichert, D., Henschler, D.: Chemical reactivity, metabolic oxirane formation and biological reactivity of chlorinated ethylenes in the isolated perfused rat liver preparation. Biochem. Pharmacol. 24, 1829–1834 (1975)
Bronzetti, G., Zeiger, E., Frezza, D.: Genetic activity of trichloroethylene in yeast. J. Environ. Path. Toxicol. 1, 411–418 (1978)
Carlson, G. P.: Enhancement of the hepatotoxicity of trichloroethylene by inducers of drug metabolism. Res. Commun. Chem. Pathol. Pharmacol. 7, 637–640 (1974)
Carlson, G. P., Fuller, G. C.: Interaction of modifiers of hepatic microsomal drug metabolism and the inhalation toxicity of 1,1-dichloroethylene. Res. Commun. Chem. Pathol. Pharmacol. 4, 553–560 (1972)
Conolly, R. B., Jaeger, R. J., Szabo, S.: Acute hepatotoxicity of ethylene, vinyl fluoride, vinyl chloride and vinyl bromide after Aroclor 1254 pretreatment. Toxicol. Appl. Pharmacol. 41, 146 (1977)
Creech, J. L., Johnson, M. N.: Angiosarcoma of the liver in the manufacture of polyvinyl chloride. J. Occup. Med. 16, 150–151 (1974)
Drevon, C., Kuroki, T., Montesano, R.: Microsome-mediated mutagenesis of a Chinese hamster cell line by various chemicals. In: Progress in genetic toxicology. Scott, D., Bridges, B. A., Sobels, F. H. (eds.), pp. 207–213. Amsterdam: Elsevier/North Holland Biomedical Press 1977
Fishbein, L.: Industrial mutagens and potential mutagens. I. Halogenated aliphatic derivatives. Mutat. Res. 32, 267–308 (1976)
Garro, A. H., Guttenplan, J. B., Milvy, P.: Vinyl chloride dependent mutagenesis: effects of liver extracts and free radicals. Mutat. Res. 38, 81–88 (1976)
Göthe, R., Callermann, C. J., Ehrenberg, L., Wachtmeister, C. A.: Trapping with 3,4-dichlorobenzenethiol of reactive metabolites formed in vitro from the carcinogen vinyl chloride. Ambio 3, 234–236 (1974)
Green, T., Hathway, D. E.: The chemistry and biogenesis of the S-containing metabolites of vinyl chloride in rats. Chem.-Biol. Interact. 17, 137–150 (1977)
Green, T., Hathway, D. E.: Interactions of vinyl chloride with rat liver DNA in vivo. Chem.-Biol. Interact. 22, 211–224 (1978)
Greim, H., Bonse, G., Radwan, Z., Reichert, D., Henschler, D.: Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxirane formation. Biochem. Pharmacol. 24, 2013–2017 (1975)
Hadjiolov, D., Mundt, D.: Effect of aminoacetonitrile on the metabolism of dimethylnitrosamine and methylation of RNA during liver carcinogenesis. J. Natl. Cancer Inst. 52, 753–756 (1974)
Henschler, D.: Metabolism of chlorinated alkenes and alkanes as related to toxicity. J. Environ. Pathol. Toxicol. 1, 125–133 (1977)
Henschler, D., Eder, E., Neudecker, T., Metzler, M.: Carcinogenicity of trichloroethylene: Fact or artifact? Arch. Toxicol. (Berl.) 37, 233–236 (1977)
Huberman, E., Bartsch, H., Sachs, L.: Mutation induction in Chinese hamster cells by two vinyl chloride metabolites, chloroethylene oxide and 2-chloroacetaldehyde. Int. J. Cancer 16, 639–644 (1975)
Hussain, S., Ostermann-Golkar, S.: Comment on the mutagenic effectiveness of vinyl chloride metabolites. Chem.-Biol. Interact. 12, 265–267 (1976)
Infante, P. F., Wagoner, J. K., Young, R. J.: Chloroprene: Observations of carcinogenesis and mutagenesis. In: Origins of human cancer. Hiatt, H. H., Watson, J. D., Winsten, J. A. (eds.), Book A, pp. 205–217. Cold Spring Harbor Laboratory, 1977
International Agency for Research on Cancer: IARC monographs on the evaluation of the carcinogenic risk of chemicals to man, vol. 11. Cadmium, nickel, some epoxides, miscellaneous industrial chemicals and general considerations on volatile anaesthetics. Lyon, 1976
International Agency for Research on Cancer: IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol. 19. Some plastics and synthetic elastomers — monomers, homopolymers and copolymers. Lyon (In press, 1978/1979)
Ivanetich, K. M., Aronson, E., Katz, E. D.: The interaction of vinyl chloride with rat hepatic microsomal cytochrome P-450 in vitro. Biochem. Biophys. Res. Commun. 74, 1411–1418 (1977)
Jaeger, R. J., Conolly, R. B., Reynolds, E. S., Murphy, S. D.: Biochemical toxicology of unsaturated halogenated monomers. Environ. Health Perspect 11, 121–128 (1975)
Jaeger, R. J., Murphy, S. D., Reynolds, E. S., Szabo, S., Moslen, M. T.: Chemical modification of acute hepatotoxicity of vinyl chloride monomer in rats. Toxicol. Appl. Pharmacol. 41, 597–607 (1977)
Johnson, M. K.: Metabolism of chloroethanol in rat. Biochem. Pharmacol. 16, 185–199 (1967)
Jones, B. K., Hathway, D. E.: The biological fate of vinylidene chloride in rats. Chem.-Biol. Interact. 20, 27–41 (1978)
Kappus, H., Bolt, H. M., Buchter, A., Bolt, W.: Rat liver microsomes catalyse covalent binding of 14C-vinyl chloride to macromolecules. Nature 257, 134–135 (1975)
Kappus, J., Bolt, H. M., Buchter, A., Bolt, W.: Liver microsomal uptake of [14C]vinyl chloride and transformation to protein alkylating metabolites in vitro. Toxicol. Appl. Pharmacol. 37, 461–471 (1976)
Laib, R. J., Bolt, H. M.: Alkylation of RNA by vinyl chloride metabolites in vivo: formation of 1,N 6-etheno-adenosine. Toxicology 8, 185–195 (1977)
Laib, R. J., Bolt, H. M.: Formation of 3,N 4-ethenocytidine moieties in RNA by vinyl chloride metabolites in vitro and in vivo. Arch. Toxicol. (Berl.) 39, 235–240 (1978)
Loprieno, N., Barale, R., Baroncelli, S., Bauer, C., Bronzetti, G., Camellini, A., Cercignani, G., Corsi, C., Gervasi, G., Leporini, C., Nieri, R., Rossi, A., Stretti, G., Turchi, G.: Evaluation of the genetic effects induced by vinyl chloride monomer (VCM) under mammalian metabolic activation: studies in vitro and in vivo. Mutat. Res. 40, 85–96 (1976)
Loprieno, N., Barale, R., Baroncelli, S., Bartsch, H., Bronzetti, G., Cammellini, A., Corsi, C., Frezza, D., Nieri, R., Leporini, C., Rosellini, D., Rossi, A. M.: Induction of gene mutations and gene conversions by vinyl chloride metabolites in yeast Cancer Res. 36, 253–257 (1977)
Malaveille, C., Bartsch, H., Barbin, A., Camus, A.-M., Montesano, R., Croisy, A., Jacquignon, P.: Mutagenicity of vinyl chloride, chloroethylene oxide, chloroacetaldehyde and chloroethanol. Biochem. Biophys. Res. Commun. 63, 363–370 (1975)
Malaveille, C., Planche, G., Bartsch, H.: Factors for efficiency of the Salmonella microsome mutagenicity assay. Chem.-Biol. Interact. 17, 129–136 (1977)
Maltoni, C., Lefemine, G.: Carcinogenicity bioassays of vinyl chloride: Current results. Ann. N.Y. Acad. Sci. 246, 195–218 (1975)
McCann, J., Simmon, V., Streitwieser, D., Ames, B. N.: Mutagenicity of chloroacetaldehyde, a possible metabolic product of 1,2-dichloroethane (ethylene dichloride), chloroethanol (ethylene chlorohydrin), vinyl chloride and cyclophosphamide. Proc. Natl. Acad. Sci. USA 72, 3190–3193 (1975)
Meester, C. de, Poncelet, F., Roberfroid, D., Mercier, M.: Mutagenicity of butadiene and butadiene monoxide. Biochem. Biophys. Res. Commun. 86, 298–305 (1978)
Montesano, R., Bartsch, H.: Carcinogenic and mutagenic properties of nitrosamines and nitrosamides. Mutat Res. 32, 179–228 (1975)
Moslen, M. T., Reynolds, E. S., Szabo, S.: Enhancement of the metabolism and hepatotoxicity of trichloroethylene and perchloroethylene. Biochem. Pharmacol. 26, 369–375 (1977)
Muenzer, M., Heder, K.: Results of industrial-medical and technical examination of chemical purification operations. Zentralbl. Arbeitsmed. Arbeitsschutz Prophyl. 22, 133–138 (1972)
National Cancer Institute: Bioassay of tetrachloroethylene for possible carcinogenicity. DHEW Publication No. (NIH) 77-813, Carcinogenesis Technical Report Series No. 13 (1977)
Nyström, A. E.: Health hazards in the chloroprene rubber industry and their prevention. A clinical and experimental study with special reference to chloroprene and its oxidation and polymerization products. Acta Med. Scand. 132 (Suppl. 219), 1–125 (1948)
Ostermann-Golkar, S., Hultmark, D., Segerbäck, D., Calleman, C. J., Göthe, R., Ehrenberg, L., Wachtmeister, C. A.: Alkylation of DNA and proteins in mice exposed to vinyl chloride. Biochem. Biophys. Res. Commun. 76, 259–266 (1977)
Powell, J. F.: Trichloroethylene: absorption, elimination and metabolism. Br. J. Ind. Med. 2, 142–145 (1945)
Rannug, U., Johansson, A., Ramel, C., Wachtmeister, C. A.: Mutagenicity of vinyl chloride after metabolic activation. Ambio 3, 194–197 (1974)
Rannug, U., Göthe, R., Wachtmeister, C. A.: The mutagenicity of chloroethylene oxide, chloroacetaldehyde, 2-chloroethanol and chloroacetic acid, conceivable metabolites of vinyl chloride. Chem.Biol. Interact. 12, 251–263 (1976)
Reynolds, E. S., Moslen, M. T., Szabo, S., Jaeger, R. J., Murphy, S. D.: Hepatotoxicity of vinyl chloride and 1,1-dichloroethylene. Am. J. Pathol. 81, 219–236 (1975a)
Reynolds, E. S., Moslen, M. T., Szabo, S., Jaeger, R. J.: Vinyl chloride-induced deactivation of cytochrome P-450 and other components of the liver mixed function oxidase system: an in vivo study. Res. Commun. Chem. Pathol. Pharmacol. 12, 685–594 (1975b)
Sabadie, N., Malaveille, C., Camus, A. M., Brun, G., Bartsch, H.: Vinyl chloride, N-nitrosomorpholine, and N-nitroso-N′-methylpiperazine mutagenicity associated with benzo(a)pyrene-hydroxylase activity in human and rat liver in vitro, Abstract. XIIth Int. Cancer Congress, Buenos Aires, 1978
Schmähl, D., Krüger, F. W., Habs, M., Diehl, B. P.: Influence of disulfiram on the organotropy of the carcinogenic effect of dimethylnitrosamine and diethylnitrosamine in rats. Z. Krebsforsch. 85, 271–276 (1976)
Semmelhack, M. F., Foos, J. S., Katz, S.: Spiro-[4.4]-nonatetraene and spiro-[4.4]-nona-[1,3,7]-triene-synthesis and properties. Effects of spiroconjugation. J. Am. Chem. Soc. 95, 7325–7336 (1973)
Shahin, M. M.: The non-mutagenicity and recombinogenicity of vinyl chloride in the absence of metabolic activation. Mutat. Res. 40, 269–272 (1976)
Shahin, M. M., Von Borstel, R. C.: Mutagenic and lethal effects of α-benzene hexachloride, dibutylphthalate, and trichloroethylene in Saccharomyces cerevisiae. Mutat. Res. 48, 173–180 (1977)
Short, R. D., Winston, J. M., Minor, J. L., Seifter, J., Lee, C.-C.: Effect of various treatments on toxicity of inhaled vinylidene chloride. Environ. Health Perspect. 21, 125–129 (1977)
Simmon, V. F., Kauhanen, K., Tardiff, R. G.: Mutagenic activity of chemicals identified in drinking water. In: Progress in genetic toxicology. Scott, D., Bridges, B. A., Sobels, F. H. (eds.), pp. 249–258. Amsterdam: Elsevier/North Holland Biomedical Press 1977
Strömme, H. J.: Metabolism of disulfiram and diethyldithiocarbamate in rats with demonstration of an in vivo ethanol-induced inhibition of the glucuronic acid conjugation of the thiol. Biochem. Pharmacol. 14, 393–410 (1965)
Uehleke, H., Poplawski-Tabarelli, S.: Irreversible binding of 14C-labelled trichloroethylene to mice liver constituents in vivo and in vitro. Arch. Toxicol. (Berl.) 37, 289–294 (1977)
Uehleke, H., Tabarelli-Poplawski, S., Bonse, G., Henschler, D.: Spectral evidence for 2,2,3-trichlorooxirane formation during microsomal trichloro-ethylene oxidation. Archiv. Toxicol. (Berl.) 37, 95–105 (1977)
Van Duuren, B. L.: On the possible mechanism of carcinogenic action of vinyl chloride. Ann. N.Y. Acad. Sci. 246, 258–267 (1975)
Van Duuren, B. L., Banerjee, S.: Covalent interaction of metabolites of the carcinogen trichloroethylene in rat hepatic microsomes. Cancer Res. 36, 2419–2422 (1976)
Van Duuren, B. L., Goldschmidt, B. M., Seidman, I.: Carcinogenic activity of di-and trifunctional α-chloro ethers and of 1,4-dichlorobutene-2 in ICR/HA Swiss mice. Cancer Res. 35, 2553–2557 (1975)
Van Duuren, B. L., Katz, C., Goldschmidt, M., Freubel, K., Slvak, A.: Carcinogenicity of halo-ethers. II. Structure activity relationship of analogs of bis(chloromethyl)ether. J. Natl. Cancer Inst. 48, 1431–1439 (1972)
Vogel, E.: Mutagenicity of carcinogens in Drosophila as a function of genotype-controlled metabolism. In: In vitro metabolic activation in mutagenesis testing, de Serres, F. J., Fouts, J. R., Bend, J. R., Philpot, R. M. (eds.), pp. 62–79. Amsterdam: Elsevier/North Holland Biomedical Press 1976
Watanabe, P. G., Hefner, R. E., Gehring, P. J.: Vinyl chloride-induced depression of hepatic nonprotein sulfhydryl content and effects on bromosulphthalein (BSP) clearance in rats. Toxicology 6, 1–8 (1976)
Zemaitis, M. A., Greene, F. E.: Impairment of hepatic microsomal drug metabolism in the rat during daily disulfiram administration. Biochem. Pharmacol. 25, 1355–1360 (1976)
Author information
Authors and Affiliations
Additional information
Work in part fulfillment of a thesis at the University of Lyon, France, 1977
Rights and permissions
About this article
Cite this article
Bartsch, H., Malaveille, C., Barbin, A. et al. Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadienes and dichlorobutenes produced by rodent or human liver tissues. Arch. Toxicol. 41, 249–277 (1979). https://doi.org/10.1007/BF00296896
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00296896